Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 34.50% is 157% above its 4-year average of 13.40%, near the high end of its 4-year range (5.93%–34.50%).
52.69% above its 12-month average of 22.59%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
34.50%
RETURN ON ASSETS (ROA) AVG TTM
22.59%
RETURN ON ASSETS (ROA) AVG 3Y
17.42%
RETURN ON ASSETS (ROA) AVG 5Y
13.40%
RETURN ON ASSETS (ROA) AVG 10Y
14.96%
RETURN ON ASSETS (ROA) AVG 15Y
3.47%
RETURN ON ASSETS (ROA) AVG 20Y
-9.27%
CURRENT VS TTM AVG
+52.69%
CURRENT VS 3Y AVG
+98.09%
CURRENT VS 5Y AVG
+157.42%
CURRENT VS 10Y AVG
+130.66%
CURRENT VS 15Y AVG
+893.01%
CURRENT VS 20Y AVG
+472.19%
SECTOR MEDIAN · HEALTHCARE
4.97%
median of 77 covered companies
CURRENT VS SECTOR MEDIAN
+594.16%
vs the sector median at left
Exelixis, Inc.
Market Cap
$13.59B
Return on Assets (ROA)
34.50%
TTM Avg
22.59%
3Y Avg
17.42%
5Y Avg
13.40%
Market Cap
$13.62B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$13.92B
Return on Assets (ROA)
1.97%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
Market Cap
$14.22B
Return on Assets (ROA)
-3.17%
TTM Avg
-0.94%
3Y Avg
2.58%
5Y Avg
3.75%
Market Cap
$12.74B
Return on Assets (ROA)
-10.75%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
Market Cap
$14.87B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$15.51B
Return on Assets (ROA)
10.07%
TTM Avg
7.10%
3Y Avg
8.43%
5Y Avg
7.35%
Market Cap
$11.64B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$11.32B
Return on Assets (ROA)
7.03%
TTM Avg
4.95%
3Y Avg
6.73%
5Y Avg
7.50%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exelixis, Inc. (EXEL) | $13.59B | 34.50% | 22.59% | 17.42% | 13.40% |
| Baxter International Inc. (BAX)vs › | $13.62B | -5.37% | -3.64% | -1.62% | 0.47% |
| Revvity, Inc. (RVTY)vs › | $13.92B | 1.97% | 2.19% | 1.89% | 3.83% |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.22B | -3.17% | -0.94% | 2.58% | 3.75% |
| Tempus AI, Inc. (TEM)vs › | $12.74B | -10.75% | -43.49% | -42.71% | -41.26% |
| The Cooper Companies, Inc. (COO)vs › | $14.87B | 1.89% | 3.10% | 3.02% | 7.71% |
| Solventum Corporation (SOLV)vs › | $15.51B | 10.07% | 7.10% | 8.43% | 7.35% |
| Align Technology, Inc. (ALGN)vs › | $11.64B | 6.44% | 6.68% | 6.69% | 12.75% |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 7.03% | 4.95% | 6.73% | 7.50% |
| DaVita Inc. (DVA)vs › | $11.16B | 4.79% | 4.84% | 4.27% | 4.56% |
ROA
34.5%
ROE
46.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-01-02 | 27.51% |
| 2025-01-03 | 17.68% |
| 2023-12-31 | 7.06% |
| 2022-12-31 | 5.93% |
| 2021-12-31 | 8.83% |
| 2020-12-31 | 5.23% |
| 2019-12-31 | 17.02% |
| 2018-12-31 | 48.52% |
| 2017-12-31 | 23.54% |
| 2016-12-31 | -11.75% |
| 2015-12-31 | -51.07% |
| 2014-12-31 | -81.88% |
| 2013-12-31 | -48.63% |
| 2012-12-31 | -20.48% |
| 2011-12-31 | 19.25% |
| 2010-12-31 | -25.59% |
| 2009-12-31 | -39.38% |
| 2008-12-31 | -40.55% |
| 2007-12-31 | -20.96% |
| 2006-12-31 | -25.67% |
| 2005-12-31 | -25.37% |
| 2004-12-31 | -47.11% |
| 2003-12-31 | -26.49% |
| 2002-12-31 | -25.40% |
| 2001-12-31 | -20.54% |
| 2000-12-31 | -36.75% |
| 1999-12-31 | -98.94% |
| 1998-12-31 | -174.43% |
